FOXL2 Is a Female Sex-Determining Gene in the Goat  by Boulanger, Laurent et al.
FOXL2 Is a Female Sex-DeteCurrent Biology 24, 404–408, February 17, 2014 ª2014 Elsevier Ltd All rights reserved http://dx.doi.org/10.1016/j.cub.2013.12.039Report
rmining
Gene in the GoatLaurent Boulanger,1,4 Mae¨lle Pannetier,1,4 Laurence Gall,1
Aure´lie Allais-Bonnet,1 Mae¨va Elzaiat,1 Daniel Le Bourhis,1,2
Nathalie Daniel,1 Christophe Richard,1 Corinne Cotinot,1
Norbert B. Ghyselinck,3 and Eric Pailhoux1,*
1INRA, UMR 1198 Biologie du De´veloppement et
Reproduction, 78350 Jouy-en-Josas, France
2UNCEIA R&D, 13 Rue Joue¨t, 94704 Maisons-Alfort, France
3Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire
(IGBMC), Inserm U964, CNRS UMR 7104, University of
Strasbourg (UdS), Department of Functional Genomics and
Cancer, 1 Rue Laurent Fries, BP10142, 67404 Illkirch Cedex,
France
Summary
The origin of sex reversal in XX goats homozygous for
the polled intersex syndrome (PIS) mutation was unclear
because of the complexity of the mutation that affects the
transcription of both FOXL2 and several long noncoding
RNAs (lncRNAs) [1, 2]. Accumulating evidence suggested
that FOXL2 could be the sole gene of the PIS locus respon-
sible for XX sex reversal, the lncRNAs being involved in
transcriptional regulation of FOXL2 [2]. In this study, using
zinc-finger nuclease-directed mutagenesis, we generated
several fetuses, of which one XX individual bears biallelic
mutations of FOXL2. Our analysis demonstrates that
FOXL2 loss of function dissociated from loss of lncRNA
expression is sufficient to cause an XX female-to-male sex
reversal in the goat model and, as in the mouse model, an
agenesis of eyelids. Both developmental defects were repro-
duced in two newborn animals cloned from the XX FOXL22/2
fibroblasts. These results therefore identify FOXL2 as a
bona fide female sex-determining gene in the goat. They
also highlight a stage-dependent role of FOXL2 in the ovary,
different between goats and mice, being important for fetal
development in the former but for postnatal maintenance
in the latter.Results
In goats, the polled intersex syndrome (PIS) mutation associ-
ates an absence of horns in heterozygous and homozygous
animals of both sexes (dominant trait) and a female-to-male
sex reversal in biallelic affected XX animals (recessive and
sex-limited trait) [1]. This syndrome arises from a complex reg-
ulatory deletion of 11.7 kb locatedw300 kb upstream from the
FOXL2 gene and inducing (1) loss of FOXL2 expression and (2)
transcription arrest of three long noncoding RNAs (lncRNAs)
named PISRT1, the ‘‘long transcripts’’ (also called PISRT2),
and PFOXic; these lncRNAs are located around either the
PIS region or FOXL2 [1–3]. FOXL2 transcription normally
initiates between 34 and 36 days postcoitum (dpc) in a sub-
population of somatic cells located in the deepest medulla of
the XX gonad [4, 5]. This developmental stage corresponds4These authors contributed equally to this work
*Correspondence: eric.pailhoux@jouy.inra.frto the gonadic switch, i.e., the time point at which male sex
determination is instructed by increase of SOX9 expression
in the XY gonad [4]. The biallelic PIS mutation yields an
absence of FOXL2 transcription from 34–36 dpc onward in
XX developing gonads, associated with an upregulation of
SOX9 expression and differentiation of the somatic cells of
the gonad as testicular cells, with a 4–5 day delay when
compared to normal testis development [4]. These findings
suggested that either FOXL2 or the lncRNAs (or both) could
act as female sex-determining genes. In mice, however,
although Foxl2 expression is also detected from the gonadic
switch time point (i.e., 12 dpc) onward, as in goats, its biallelic
loss of function does not induce sex reversal of somatic
cells until after birth [6, 7]. This finding established Foxl2 as
necessary to maintain female identity of the somatic compart-
ment of the gonad during postnatal life, but casted doubts on
Foxl2 acting as a female sex-determining gene at the gonadic-
switch time period.
To clarify the involvement of FOXL2 during ovarian dif-
ferentiation in goats and to elucidate its role in PIS, we have
generated FOXL2 loss-of-function mutations in wild-type
goats using a FOXL2-selective zinc-finger nuclease (ZFN)
and optimized the protocol as detailed in the Experimental
Procedures.
FOXL2 Ablation in Goats Leads to Female-To-Male Sex
Reversal and Ablephary
This work reports the first gene targeting in goats using
ZFN mRNAs microinjected into fertilized oocytes. All of the
mutations obtained arise at the expected ZFN-cutting site,
located 72 bp downstream of the ATG start codon and
upstream of the region coding the forkhead DNA-binding
domain. Four goat fetuses carrying FOXL2 mutations were
produced in the same experiment (Table S1 available online).
They were recovered at 56 dpc, a stage corresponding to
the onset of female germ cell meiosis, i.e., 20 days after
the gonadic switch in goats [4]. Among them, one XY
(#922) and two XX (#923 and #925) fetuses carrying a mono-
allelic deletion of FOXL2 displayed no obvious, pathological
phenotype. They were therefore considered as controls.
Fetus #921 carried two FOXL2-mutated alleles, one with a
4 bp deletion and the other with a 54 bp deletion/+2 bp
insertion (Figure S1). This fetus appeared with an absence
of eyelids (Figure 1A) and with male external genitalia (Fig-
ure 1B), although PCR sexing revealed an XX genotype
(Figure 1C). Importantly, no FOXL2 protein was detected in
the gonad of fetus #921 (Figure 2A), confirming an efficient
FOXL2 loss of function. In agreement with a characteristic
phenotype of female-to-male sex reversal, male-specific
genes such as SOX9 and DMRT1 were detected in the
gonad of fetus #921, in Sertoli-like cells that were organized
in seminiferous cords highly similar to those observed in the
control testis #922 (Figures 2B and 2C). In addition, Leydig
cell differentiation was evident in the sex-reversed gonad
#921, as attested by expression of CYP17 enzyme in the
interstitial cells (Figure 2C), while CYP17 expression had
stopped in the control ovary #925 (Figure 2C). It is worth
noting that steroidogenesis has accordingly stopped in
the normal ovary at this stage [5]. In contrast, testosterone
Figure 1. External Appearance of Goat Fetuses
Recovered from Gene Targeting Experiments
(A) Absence of eyelids in an XX FOXL22/2 fetus
(#921) but not in heterozygous male (#922) and
female (#923) fetuses of the same litter.
(B) Appearance of the external genitalia in the
three fetuses.
(C) PCR sexing demonstrating that FOXL22/2
fetus #921 has an XX genotype.
See also Figures S1 and S2 and Table S1.
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405production in fetus #921 was functionally attested by the
complete masculinization of its external genitalia (i.e.,
fully differentiated scrotum and urogenital orifice under the
umbilicus; Figure 1B), which occurs between 40 and
50 dpc in normal XY goat fetuses [4].
To rule out ZFN-induced mosaicism in fetus #921 and to
analyze later stages of gonadic development in the absence
of FOXL2, we expanded skin fibroblasts from this founder
in vitro and used them for goat-cloning experiments [8].
Upon nuclear transfers into enucleated oocytes (n = 44),
followed by embryo transfers (n = 16) into synchronized
recipient mothers (n = 9), two XX goats (#03036 and
#03037) were recovered by cesarean section at 150 dpc,
the developmental stage corresponding to birth. Both of
them displayed the same absence of eyelids and female-to-
male sex reversal as did fetus #921 (Figure S2), demon-
strating that it had a nonmosaic composition. Interestingly
enough, both #03036 and #03037 exhibited a male reproduc-
tive system, as in PIS2/2 XX goats [9], with testis-like gonads
descended into the scrotum and fully differentiated epidi-
dymes and vas deferens, but no residual Mu¨llerian duct
derivatives. However, the location of their urogenital orifices
slightly differs from that of each other and from that of
fetus #921. It was near the scrotum in #03037, between
the scrotum and the umbilicus in #03036, and just under
the umbilicus (i.e., in a ‘‘normal’’ male position) in fetus#921 (Figures 1B and S2). Assuming
that FOXL2 deletion was the sole ge-
netic alteration in all three fetuses, this
suggests that androgen levels were
likely at the limit of the masculinizing
threshold in FOXL22/2 mutants during
the time period when the urogenital
bud is sensitive to hormone signaling
(i.e., from 40 to 50 dpc), possibly
because of the 4- to 5-day-long delay
for testis differentiation in the mutant
situation [4].
The FOXL22/2 XX Gonads Display a
Testis-like Gene Expression Profile
As expected in a situation of sex
reversal, expression of female-specific
somatic genes (i.e., RSPO1, RSPO2,
CYP19, and FST) was downregulated
in the XX FOXL22/2 gonad at 56 dpc
(Figure 3A), and, conversely, expression
of male-specific somatic genes (i.e.,
SOX9, AMH, and CYP17) was upregu-
lated (Figure 3B), as in thePIS2/2 gonad.
Moreover, germ cell fate was also sex
reversed in XX FOXL22/2 #921 gonads,as previously described in XX PIS2/2 testes at 56 dpc [4].
Indeed, meiosis initiation (attested by expression of STRA8
[10]) was restricted to control female ovaries (i.e., FOXL2+/2
or FOXL2+/+) (Figure 3C). Interestingly enough, the strong
expression of VASA in control female gonads compared to
the others suggested a higher number of germ cells in the
ovaries than in the testes and the XX sex-reversed gonads
(FOXL22/2 and PIS2/2) at this stage (Figure 3C). In keeping
with this possibility, VASA-positive cells were much more
abundant on tissue sections from FOXL2+/2 ovaries than
from FOXL2+/2 testes and FOXL22/2 sex-reversed gonads
(Figure S3). This indicates that the female-to-male sex reversal
in XX FOXL22/2 gonads occurred prior to the period of germ
cell proliferation in a normal ovary, which takes place in goats
between 36 and 56 dpc [4, 5].
Expression of PIS-Regulated Genes Persists in FOXL22/2
XX Gonads
In addition to shutting down FOXL2 gene expression in the
female gonad, the PIS mutation leads to a transcriptional
silencing of three lncRNAs [1–3]. Among these three
lncRNAs, PFOXic arises from the bidirectional FOXL2 pro-
moter (Figure 3D) and has been proposed to regulate the
level of FOXL2 protein by a mechanism of ‘‘transcriptional
overflow’’ [3]. PFOXic is a polyadenylated lncRNA showing
an expression level comparable to that of FOXL2 [3]. The
Figure 2. FOXL2 Knockout Yields a Gonad with
Testicular Characteristic Features
(A) FOXL2 is detected in the control female gonad
(#925, green signal), but neither in the male con-
trol gonad (#922) nor in the XX FOXL22/2 gonad
(#921), as expected. Nuclei are counterstained
with DAPI (blue signal).
(B and C) the XX FOXL22/2 mutant gonad (#921)
is clearly organized as the control testis (#922).
It is surrounded by the tunica albuginae (B,
top panels). Well-organized seminiferous cords
contain SOX9 and DMRT1-positive Sertoli cells
(green signals) and are surrounded by a basal
lamina that is positive for laminin (red signal;
B, bottom panel, and C). In addition, CYP17-
positive cells (red signal) were detected in the
interstitial tissue (C).
Scale bars represent the indicated measure-
ments. See also Figure S3.
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406other PISRT1 and PISRT2 lncRNAs are transcribed from a
highly conserved promoter region locatedw300 kb upstream
of FOXL2 (Figure 3D). These lncRNAs are transcribed at
a very low level when compared to FOXL2/PFOXic, but
their expression is always positively correlated to that of
FOXL2/PFOXic [1, 2, 11]. They are thus considered to be
enhancer lncRNAs, acting in cis on FOXL2/PFOXic transcrip-
tion [2, 8, 12, 13].
To test whether sex reversal in fetus #921 could be due to
deregulation of one of these lncRNAs, we measured the
expression of all four PIS-regulated genes at 56 dpc in
FOXL2 mutant and controls gonads (Figure 3D). Their expres-
sion was also assessed in XX PIS2/2 gonads for comparison
purpose. Independently of FOXL2 genotype (i.e., FOXL2+/+,
FOXL2+/2, or FOXL22/2), PISRT1 RNA levels were identical
in the XX gonads, while PISRT2 and PFOXic RNA levels were
w50% lower in FOXL22/2 than in FOXL2+/+ and FOXL2+/2 XX
gonads (Figure 3D). These results show that PIS-regulated
gene transcription is not shut down in XX FOXL22/2 gonads
as it is in the context of the PIS mutation [1, 2]. In other words,
the PIS locus remained transcriptionally active in FOXL22/2
gonads, and sex reversal occurred independently of the loss
of lncRNAs. Thus, it is unlikely that altered levels of PISRT1,
PISRT2, and PFOXic are instrumental to sex reversal in XX
FOXL22/2 mutants.Discussion
FOXL2 Is a Critical Gene for Eyelid
Development in Mammals
PIS2/2 goats harbor normal eyelids.
Indeed, the PIS mutation doesn’t affect
FOXL2 expression in developing eyelids
[1]. By contrast, we show here that
FOXL2 loss of function in goats leads
to absence of eyelids (ablephary), a
pathological phenotype never described
until now in this species, but already
observed in mice knocked out for
Foxl2 [6, 7]. In addition, FOXL2 haploin-
sufficiency in humans is responsible for
blepharophimosis, ptosis, and epican-
thus inversus syndrome (BPES; MIM
110100) [14]. Thus, either total or partial
loss-of-function mutations of FOXL2are responsible for agenesis or malformation of eyelids in
three distinct orders of mammals (namely, primates, rodents,
and artiodactyls). As a result, FOXL2 can be considered as a
crucial actor of eyelid development in mammals.
FOXL2 Is a Female Sex-Determining Gene in the Goat
We show that FOXL2 loss of function dissociated from loss of
lncRNA expression in goat ovaries leads to an early sex-
reversal phenotype, identical to the one previously described
in goats carrying the PISmutation [1, 2]. This observation dem-
onstrates that the loss of FOXL2 gene product is responsible
for the female-to-male sex reversal in PIS2/2 goats. We there-
fore identify FOXL2 as a genuine female sex-determining gene
in the goat.
Our findings therefore imply that the function of FOXL2 in
sex and ovarian differentiation occurs at distinct stages in
goats and mice, respectively. Even though Foxl2 is expressed
as early as 12.0 dpc in the mouse (i.e., at the time of the so-
called gonadic switch), its loss of function does not yield
female-to-male sex reversal [6, 7, 15]. However, Foxl2 ablation
after birth (i.e., at the time of follicle formation) yields the trans-
differentiation of two ovarian somatic cell lineages, namely
granulosa and theca cells into Sertoli and Leydig cells, respec-
tively [16]. This somatic cell sex reversal is not linked to the
germ cell fate, but occurs because FOXL2 is no longer present
Figure 3. FOXL2 Knockout Yields Gonadic Down-
regulation and Upregulation of Female-Specific
and Male Specific Genes, Respectively, without
Altering PIS-Regulated lncRNA Expression
(A) Expression of somatic female-specific genes
that are all decreased in the XX FOXL22/2 gonad
(red bars) to levels similar to those observed in
the control PIS2/2 (yellow bars) and male (blue
bars) gonads. Note that RSPO2, CYP19, and FST
are FOXL2 target genes.
(B) Expression of somatic male-specific genes
that are all increased in the XX FOXL22/2 gonad
(red bars) to levels similar to those observed in
the control PIS2/2 (yellow bars) and male (blue
bars) gonads. Note that SOX9 and AMH are
Sertoli cell-specific markers, while CYP17 is a
Leydig cell-specific marker.
(C) Expression of germ cell-specific (VASA) and
meiosis-specific (STRA8) genes, which are all
robustly expressed in control ovaries (pink bars)
and barely detectable in the XX FOXL22/2 gonad
(red bars), the control PIS2/2 gonad (yellow
bars), and the testis (blue bars). This attests a
higher number of germ cells in ovaries than
in testes and illustrates the meiotic initiation
restricted to the ovaries.
(D) Top: schematic representation of the PIS
locus. Broken arrows indicate transcription start
sites; gray boxes stand for the locations of
PISRT1, PISRT2, and PFOXic lncRNAs and for
the FOXL2 gene, as indicated; the yellow box indi-
cates the sequence altered in the PIS mutation;
and small arrow pairs indicate the locations of
primer sets used for PCR analysis. Bottom:
expression of all four PIS-regulated transcripts,
which are all maintained at a substantial level in
the XX FOXL22/2 gonad (red bars) as in control
female gonads (pink bars), while they were almost
undetectable in the testes (blue bars).
Errors bars represent the mean 6 SEM of
triplicates.
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407to synergize with the estrogen receptor alpha (ESR1) to
repress Sox9 expression after birth [16, 17]. Thus, FOXL2, in
conjunction with ESR1, is essential to maintain female identity
of the somatic compartment in the postnatal gonad [16].
To our point of view, the difference in estrogen production,
for which FOXL2 seems to play a critical function, represents
the most probable explanation for the distinct outcomes of
FOXL2/Foxl2 loss of functions in goats and mice at the time
of gonadic switch. Indeed, FOXL2 enhances aromatase
expression in goats, as in humans and inmany nonmammalian
species through its direct action on CYP19A1 ovarian-specific
promoter [5, 18–22], thereby favoring synthesis of estrogens
by the differentiating ovary, long before germ cell meiotic entry
[23, 24]. Accordingly, sheep [25, 26], rabbit [27], and human
[28] XX gonads are able to synthesize estrogens at the time
of the gonadic switch. In contrast, estrogens are not produced
at the early stages of ovarian differentiation in the mouse [29],
and, in keeping with this, neither Esr1;Esr2- nor Cyp19a1-null
mutants display sex reversal at birth [30, 31]. Therefore,
the fact that Foxl2 has lost its feminizing action during fetal
development in the mouse is most likely related to the fact
that estrogen signaling is dispensable to female sex determi-
nation during the fetal period in this species.The regulatory mechanism involving estrogens for sex
determination exists also in nonmammalian vertebrates like
fishes, amphibians, reptiles, and birds [32], making the mouse
rather an exception. It is therefore tempting to speculate that
FOXL2 is actually, in humans as in goats, a female sex-deter-
mining gene whose functioning in the mouse has been
restricted to the maintenance of the female identity of somatic
cells in the postnatal ovary [16]. However, any female-to-male
sex reversal in humans due to FOXL2 mutations should be
associated with an agenesis of the eyelids, a situation that
has never been described to our knowledge. It is, however,
possible that some cases result from complex regulatory
mutations, leading to an ovarian-specific FOXL2 loss of func-
tion as the PIS mutation does in the goat.
Experimental Procedures
Research involving goat experimentations conformed to the principles for
the use and care of animals in agricultural research and teaching, in compli-
ance with French and European regulations on animal welfare. Goat eggs
have been produced in vivo. They have been injected with two mRNAs
encoding each monomer of a specific ZFN engineered by Sigma or with a
tricistronic mRNA encoding EGFP-ZFN1-ZFN2 and engineered by our-
selves. In the tenth experiment, 23 EGFP-positive embryoswere transferred
Current Biology Vol 24 No 4
408into eight recipient goats, fromwhich five fetuses were recovered at 56 days
of gestation (fetus #921, #922, and #923 on recipient number 09072; fetus
#924 and #925 on recipient number 09025). Day 0 corresponded to the
day of natural mounting by male goats. PCR sexing, quantitative RT-PCR,
and IHC analyses were performed as previously described [4, 8]. Detailed
experimental procedures are given in the Supplemental Experimental
Procedures.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, five figures, and four tables and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.12.039.
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